INTRODUCTION
Bacillus megaterium ATCC 14581 contains at least three soluble cytochrome P-450s termed P-450 BM-" , P-450 BM-# and P-450 BM-$ [1] . Cytochromes P-450 BM-" and P-450 BM-$ have been cloned, and their genes encode polypeptides of molecular mass 47 and 117n5 kDa respectively [2, 3] . Both cytochrome P-450s are induced by barbiturates [4] , and research in our laboratory has revealed that cytochrome P-450 BM-$ is also profoundly induced by peroxisome proliferators and non-steroidal anti-inflammatory drugs [5, 6] . Investigations into the mechanism of regulation of the cytochrome P-450 BM-$ operon have identified an open reading frame located immediately 5h of cytochrome P-450 BM-$ which encodes a transcriptional repressor, termed Bm3R1 [7] . This repressor binds to a perfect palindromic operator upstream of its own open reading frame. We have demonstrated that barbiturates, peroxisome proliferators and non-steroidal anti-inflammatory drugs have a capacity to interact with Bm3R1 and to abrogate its binding to operator DNA sequences [5, 6] . The displacement of Bm3R1 from its operator by barbiturates results in the activation of transcription across both the coding regions of Bm3R1 and P-450 BM-$ [7, 8] . Furthermore the relative potency of these compounds as P-450 BM-$ inducers in i o is closely correlated with their ability to inhibit the formation of the Bm3R1-operator complex in itro [5, 6] . Further evidence illustrating the critical role of the Bm3R1 repressor in the regulation of this operon comes from the observation that a single point mutation in the DNA-binding helix-turn-helix motif of Bm3R1 leads to an inability to bind its operator and allows constitutive expression of cytochrome P-450 BM-$ [7] .
Abbreviation used : EMSA, electrophoretic mobility-shift assay. 1 To whom reprint requests and correspondence should be addressed.
transcription, were unable to induce the Bm3R1 protein. We also demonstrate that cytochrome P-450 BM-$ readily oxidizes phytanic acid, and provide evidence that, although the ω-1 hydroxy acid derivatives of phytanic acid can associate with Bm3R1, they do so with an affinity two orders of magnitude lower than the unmodified fatty acid. As a consequence, the ability of the hydroxylated product to induce cytochrome P-450 BM-$ gene expression in i o is markedly reduced. These data collectively suggest that metabolism of fatty acids by cytochrome P-450 BM-$ leads to an attenuation of their ability to activate the transcription of the BM-3 operon. This work places the action of bacterial fatty acid hydroxylases in an autoregulatory loop where they may be responsible for the inactivation or clearance of the inducing fatty acid signal.
Cytochrome P-450 BM-$ is a fatty acid hydroxylase which shares more primary sequence similarity with members of the mammalian CYP4A subfamily of fatty acid ω-hydroxylases than with any other prokaryotic mono-oxygenase [9] . The spectrum of compounds that induces cytochrome P-450 BM-$ is very similar to that which induces CYP4A enzymes in mammals [10] . This led us to speculate that the capacity of specific chemicals to induce either CYP4A or cytochrome P-450 BM-$ is due to their ability to mimic fatty acid signalling compounds. Indeed, we have shown that unsaturated fatty acids are the most effective inhibitors of Bm3R1 binding to its operator DNA sequence in itro [5] .
The role of cytochrome P-450 BM-$ in the life cycle of soil-living bacillus is unclear. As a fatty acid mono-oxygenase, it may be involved in the biosynthesis of specific fatty acids required for normal homoeostasis or provide a protection mechanism against the harmful accumulation of endogenously or exogenously produced fatty acids. In support of the latter possibility, we have found that many plant-derived unsaturated fatty acids are extremely toxic to B. megaterium ([5] ; N. English, C. N. A. Palmer, W. L. Alworth, L. Kang, V. Hughes and C. R. Wolf, unpublished work). Unsaturated fatty acids have been reported to be very effective inhibitors of phospho-relay signalling in Bacillus subtilus, which may contribute to their observed toxicity [11] . The induction of enzymes involved in the metabolism and inactivation of fatty acids would provide a logical autoregulatory loop for cells to respond to fatty acid accumulation. In the present study we have demonstrated the induction of cytochrome P-450 BM-$ by a branched-chain fatty acid, phytanic acid. We have also established that oxidation of phytanic acid by cytochrome P-450 BM-$ results in the formation of ω-1 hydroxyphytanic acid.
The ω-1 hydroxyphytanic acid has a markedly reduced capacity to inhibit Bm3R1 binding to its operator DNA sequence in itro and induce cytochrome P-450 BM-$ in i o.
EXPERIMENTAL Reagents
Phytanic acid ( 96 % pure) was purchased from Sigma. Peroxisome proliferators were a gift from Zeneca Central Toxicology Laboratories, Macclesfield, Cheshire, U.K. and from Dr. Brian Lake at Bibra, Carshalton, Surrey, U.K. Antibodies and oligonucleotides were produced at the Imperial Cancer Research Fund laboratories at Clare Hall, Potters Bar, Herts., U.K. Donkey anti-rabbit secondary antiserum was purchased from SAPU, Carluke, Lanarkshire, Scotland, U.K. B. megaterium ATCC 14581 was purchased from the American Type Culture Collection.
Growth and harvesting of cells
Growth, harvesting and preparation of bacterial extracts was as described previously [5] . B. megaterium were grown at 37 mC with aeration in 1 % (w\v) glucose salts medium described by Grelet [12] but with the additional salts 0n004 % (w\v) ammonium ferric citrate and 0n008 % (w\v) CaCl # and a supplement of 0n5 % (w\v) casamino acids, to an A '!! of 0n6. Phytanic acid and drugs were added as required in DMSO, or in the case of controls, vehicle alone was added. The final DMSO concentration did not exceed 0n5 % (v\v) in any incubation. Cells were grown for approx. 8 h, harvested by centrifugation at 2000 g, washed in icecold 0n1 M potassium phosphate buffer, pH 7n4, and lysed by sonication. Subcellular fractions were obtained by centrifugation. Supernatant fractions (30 000 g) were used for immunoblotting and electrophoretic mobility-shift assay (EMSA). All protein concentrations were quantified by the method of Lowry et al. [13] .
Protein immunoblotting
SDS\PAGE and immunoblotting were performed using standard protocols [14, 15] . Briefly, proteins within the B. megaterium 30 000 g supernatant extract (30 µg) were resolved using SDS\PAGE. A 7n5 % acrylamide gel was used to resolve cytochrome P-450 BM-$ , and a 12n5 % gel was used for the detection of the Bm3R1 protein. After separation by SDS\PAGE, the proteins were transferred to nitrocellulose. Both cytochrome P-450 BM-$ and Bm3R1 protein were identified using a polyclonal rabbit antiserum (1 : 2000) , raised to the reductase domain of BM-3 and the purified recombinant repressor respectively [5] , followed by donkey anti-rabbit serum (1 : 2000) conjugated with horseradish peroxidase. 4-Chloro-1-naphthol was used as the peroxidase substrate. To increase the sensitivity of the Western blot, filters were further incubated for 60 min with Protein A labelled with #&I followed by extensive washing [16] . Bands were then visualized by autoradiography.
Cloning of Bm3R1
Bm3R1 was cloned, expressed and purified as described previously [5] .
EMSA
EMSAs were carried out by established protocols [17] . A doublestranded oligonucleotide, encompassing the binding site of Bm3R1 (5h-CGGAATGAACGTTCATTCCG-3h) [9] , was incubated with B. megaterium 30 000 g supernatant extracts (20 µg). All assays were carried out in 20 µl (final volume) EMSA buffer [60 mM KCl, 12 mM Hepes, 1 mM EDTA, 1 mM dithiothreitol and glycerol (10 %, v\v)] containing 2 µg of carrier DNA poly(dl-dC) at room temperature for 15 min. Radioactive oligonucleotide (1 ng) was then added and the sample incubated for a further 15 min at room temperature. Drugs, diluted in EMSA buffer, were added to the incubations before the addition of the oligonucleotide. After incubation the entire sample was loaded on to a 4 % non-denaturing polyacrylamide gel, electrophoresed at 16 mA constant current, dried and autoradiographed. A similar protocol was adopted when recombinant Bm3R1 protein was used. In this case, 1 µg of Bm3R1 was used in each reaction. The binding specificity of Bm3R1 to its operator sequence has been demonstrated previously using mutant and non-specific competitor oligonucleotides [5, 7] . Antibodies to Bm3R1 were used to establish the presence of this protein in the DNA-protein complex. Crude extract (30 µg) obtained from nafenopin (100 µM)-, Wy14643 (100 µM)-and phytanic acid (400 µM)-treated cells were incubated with 1 µl of undiluted antiserum to Bm3R1 or preimmune serum for 15 min before probe addition and then for a further 10 min at room temperature. This antibody has been shown to exhibit a high specificity for Bm3R1 [5] .
Assay of cytochrome P-450 BM-3 -associated fatty acid oxidation
This was carried out by measuring substrate-induced NADPH oxidation, essentially as described previously [5] except that oleic acid was used as the fatty acid substrate.
Cytochrome P-450 BM-3 -mediated oxidation of phytanic acid
Substrate-dependent NADPH oxidation activities were determined in 0n1 M potassium buffer, pH 7n4, at room temperature, as described by Black et al. [18] . The rate of NADPH oxidation was measured in the presence of purified recombinant cytochrome P-450 BM-$ (expressed in Escherichia coli), phytanic acid and NADPH using a Cary 3E UV-visible spectrophotometer. The concentration of purified cytochrome P-450 BM-$ was determined as described by Omura and Sato [19] . Buffer, enzyme and substrate were added to a 1 cm quartz cuvette to establish a reference absorbance, and 200 µM NADPH was then added to initiate the reaction. The phytanic acid substrate was added as a solution in DMSO.
The Michaelis constant (K m ) and V max of phytanic acid were derived from direct linear plots of the initial rate (V o ), of the cytochrome P-450 BM-$ -dependent reaction versus substrate concentration [S], as described by Cornish-Bowden [20] . This method uses median estimates to reduce the relative error. The Sigmaplot Scientific Graph System Version 4.14 from Jandel corporation was used to determine the V o of each reaction from the original recorded data and was used to plot the data.
Purification and analysis of the hydroxy acid derivatives of phytanic acid
Phytanic acid (5 mg ; 16 µmol) in 160 µl of DMSO was mixed with 290 nM purified cytochrome P-450 BM-$ in 30 ml of 0n1 M potassium phosphate buffer, pH 7n4, incubated at room temperature for 5 min, and then 10 ml of an NADPH-generating system added. The NADPH-generating system was produced by incubating 4n42 mM glucose 6-phosphate, 1n0 mM NADP + and 3n02 mM MgCl # in 10 ml of 0n1 M potassium phosphate buffer, pH 7n4, at 37 mC for 5 min, then adding 0n5 unit of glucose-6-phosphate dehydrogenase, type XI (Sigma Chemical Co., St. Louis, MO, U.S.A.), and incubating the resulting solution at 37 mC for another 5 min. After 30 min at 37 mC the reaction was terminated by the addition of 4 ml of 1 M HCl, which reduced the pH to 2n0. Ethyl acetate (50 ml) was then added, the mixture mixed thoroughly with a vortex mixer and then centrifuged for 20 min. The resulting ethyl acetate phase was separated, and the extraction was repeated. The combined extracts were dried with Na # SO % and the ethyl acetate evaporated. The residue was then resuspended in 100 µl of SIGMA-SIL-A reagent and analysed using a Shimadzu QP 5000 GC-MS. A DB5-MS column was used with helium as the carrier gas. The separation was performed at 60 mC for 4 min, and then the temperature was increased at 30 mC\min to a final value of 300 mC.
Parallel extracts were resuspended in DMSO and used in EMSA experiments to examine whether the phytanic acid metabolites could be used to displace the Bm3R1 repressor from its palindromic operator.
RESULTS
In previous work we demonstrated that peroxisome proliferators and non-steroidal anti-inflammatory drugs were effective inducers of cytochrome P-450 BM-$ in B. megaterium [5] . The rationale for these observations was that foreign compounds may mimic fatty acids or similar signalling molecules in the regulation of this gene. To gain further insight into the interactions with this system, we chose to study the effect of phytanic acid on events that are associated with the induction of the cytochrome P-450 BM-$ operon.
Phytanic acid has the advantage that, unlike many other fatty acids, particularly unsaturated fatty acids, it is relatively non- 
Figure 1 Effects of phytanic acid on cytochrome P-450 BM-3 expression
Cytosolic proteins (20 µg) from cells treated with the increasing concentrations of phytanic acid were subjected to Western-blot analysis using an antibody to cytochrome P-450 BM-3 . Lanes were, from left to right, DMSO-treated, 100, 200 and 400 µM phytanic acid-treated cells. It has been reported that barbiturates induce the transcription of both the BM3 and the Bm3R1 repressor genes [7] . To establish that this was the case for the peroxisome proliferators and phytanic acid, Western blots using an antibody to Bm3R1 were carried out on supernatant fractions from cells treated with these compounds. Phytanic acid, as well as the peroxisome proliferators, Wy14643 and nafenopin, were effective inducers of Bm3R1 expression (Figure 2) . Surprisingly, the three barbiturates tested, although capable of inducing cytochrome P-450 BM-$ (results not shown), did not induce Bm3R1 protein to a measurable extent (Figure 2) . The presence or absence of Bm3R1 in the cell extracts was confirmed by EMSA using a synthetic oligonucleotide corresponding to the Bm3R1 operator site. Cell extracts from phytanic acid-treated cultures showed increased protein-DNA complex formation in a manner dependent on the dose of the inducing agent ( Figure 3A) . The binding of Bm3R1 to DNA is not affected by the inducing agent in these assays as the inducing agent is removed during the lysis procedure. Increased complex formation was also observed with cell extracts prepared from cultures that had been treated with peroxisome proliferators, nafenopin and Wy14643 ( Figure 3B ). In agreement with the Western-blot analysis, no detectable complex was observed when extracts obtained from cells grown in the presence of barbiturates were used ( Figure 3C ). To verify that Bm3R1 was a major component of this complex, two experiments were performed. In the first, extracts from the peroxisome proliferatorand phytanic acid-treated cells were incubated with a polyclonal antiserum to Bm3R1. This treatment completely inhibited complex formation ( Figure 3B ). Incubation with preimmune serum had essentially no effect on DNA-binding activity. This experiment alone does not preclude an indirect effect of Bm3R1 on the observed complex ; however, in our second experiment we show that purified Bm3R1 binds directly to the operator sequence ( Figure 3D ). We also exploited the difference in molecular mass and charge of the endogenous and recombinant BMR1 that results from the presence of a histidine tag on the recombinant protein. In this experiment, recombinant Bm3R1 was added in increasing concentrations to the EMSA containing a constant amount of crude extract. The subsequent non-denaturing electrophoresis of this mixture resulted in an incremental loss of the endogenous complex with the faster mobility and the appearance of both a complex corresponding to the slower recombinant Bm3R1-DNA complex and a novel complex of intermediate mobility. This complex of intermediate mobility would suggest that the recombinant Bm3R1 is forming heterodimers with the endogenous binding activity. At high concentrations of recombinant Bm3R1, mainly homodimers of the recombinant Bm3R1 are observed. In addition to demonstrating that the complex formed in the cell extracts contains Bm3R1, these observations suggest that Bm3R1 binds to the operator as a homodimer. The above data, however, cannot exclude the possibility that, in the cell extracts, the Bm3R1 may also be present in heterodimeric complexes with unknown proteins of a similar mass.
The above experiments demonstrate that a fatty acid present in the natural environment has the capacity to induce cytochrome P-450 BM-$ by a mechanism probably involving binding to the repressor Bm3R1. To establish that such fatty acids are substrates of cytochrome P-450 BM-$ , we studied whether cytochrome P-450 BM-$ could metabolize phytanic acid. Incubation of increasing concentrations of phytanic acid with cytochrome P-450 BM-$ caused a dose-dependent increase in the rate of NADPH oxidation (Figure 4) . Cornish-Bowden analysis of the resulting data confirms that phytanic acid is a good substrate for cytochrome P-450 BM-$ , with a calculated K m of 20 µM. Indeed, under these assay conditions, phytanic acid proved to be a higher-affinity substrate for cytochrome P-450 BM-$ than palmitic acid, which had an estimated K m of 60n5 µM (results not shown).
To establish clearly that the phytanic acid was oxidized by cytochrome P-450 BM-$ , the products of the incubation were analysed. TLC analysis of the reaction products clearly demonstrated the accumulation of a metabolite of phytanic acid (results not shown), and this metabolite was identified unambiguously by MS analysis as the ω-1 hydroxyphytanic acid ( Figure 5 ).
The ω-1 hydroxylation product was tested for its ability to interact with the Bm3R1-operator complex using EMSA. In- Figure 4 Evidence that phytanic acid is a substrate for cytochrome P-450 Phytanic acid metabolism was measured using substrate-induced NADPH oxidation as outlined in the Experimental section. A Cornish-Bowden plot of the resulting data is shown. The Michaelis constants, K m and V m , for phytanic acid metabolism derived from the above plot are 20 µM and 0n015 ∆A 340 /s (3n11i10 3 nmol of NADPH/min per nmol of cytochrome P-450 BM-3 ) respectively for 46n7 nM cytochrome P-450 BM-3 .
triguingly, the hydroxyphytanic acid could only displace the repressor from its operator at concentrations between 50 and 100 µM, whereas phytanic acid was shown to be far more potent, being able to inhibit Bm3R1-DNA binding at concentrations between 1 and 5 µM (Figure 6 ). Furthermore, on incubation of B. megaterium cells with 200 µM hydroxyphytanic acid, the cytochrome P-450 BM-$ -associated fatty acid hydroxylase activity was increased from 11 to 18 nmol\min per mg. This is a very poor induction compared with the levels achieved by treatment with phytanic acid (89 nmol\min per mg). This difference in potency between phytanic acid and hydroxyphytanic acid is in agreement with the EMSA studies, which showed that the hydroxyphytanic acid only displaced the repressor from its operator at very high concentrations. It is also possible that differences in uptake or clearance may contribute to the lack of potency of the hydroxyphytanic acid in the induction of cytochrome P-450 BM-$ activity. It is noteworthy, however, that considerably higher concentrations of phytanic acid were required to induce cytochrome P-450 BM-$ gene expression in i o, compared with the concentrations needed to abrogate the Bm3R1-DNA complex in itro. The reason for this is unclear but could be explained by the metabolism of phytanic acid by cytochrome P-450 BM-$ or other fatty acid-modifying enzymes. These data demonstrate that the metabolized form of phytanic acid has a greatly reduced capacity to induce cytochrome P-450 BM-$ expression.
DISCUSSION
In previous reports we have shown that foreign compounds with the capacity to induce cytochrome P-450 fatty acid monooxygenases in mammals also have the ability to induce a fatty acid mono-oxygenase in B. megaterium [5, 6] . The finding that in B. megaterium, peroxisome proliferators and non-steroidal antiinflammatory drugs can dissociate the Bm3R1 repressor from its operator DNA sequence thus leading to the activation of transcription of the cytochrome P-450 BM-$ gene has led us to hypothesize that these compounds are mimicking the actions of fatty acids. The fact that many of them form CoA esters supports this hypothesis. It has long been proposed that nonsteroidal anti-inflammatory drugs function by the competitive inhibition of arachidonic acid metabolism by cyclo-oxygenase-1 and -2. This concept has been reinforced by the co-crystallization of cyclo-oxygenase-2 and ibuprofen ; ibuprofen was found to be bound to the arachidonic acid-binding site of the molecule [21] . This further strengthens the argument that specific drugs and environmental chemicals can modulate patterns of gene expression by mimicking fatty acids.
It is still not clear whether the endogenous activator of cytochrome P-450 BM-$ expression is a fatty acid or another endogenous signalling molecule. However, in this study we have clearly shown that a specific fatty acid can be an effective inducer of cytochrome P-450 BM-$ and provide evidence that its mechanism of action involves interaction with the Bm3R1 repressor. This interaction results in the activation of transcription of both Bm3R1 and cytochrome P-450 BM-$ . Close parallels between this mode of action and that observed with the peroxisome proliferators were observed. It is interesting to note, however, that, unlike these compounds, the barbiturates did not cause a significant induction of the Bm3R1 protein. It has been reported by Shaw and Fulco [7] that Bm3R1 mRNA is increased after the administration of barbiturates. This indicates that the lack of induction of Bm3R1 may be due to some post-transcriptional event. The mechanism of this differential regulation of Bm3R1 expression is currently under investigation. We have also demonstrated that phytanic acid is a substrate for cytochrome P-450 BM-$ . As a consequence, an ω-1 hydroxylated product is formed with a markedly reduced affinity for the Bm3R1 repressor as well as a reduced capacity to induce cytochrome P-450 BM-$ . This would provide an elegant regulatory loop for the regulation of cytochrome P-450 BM-$ expression by fatty acids. Whether there are endogenous fatty acid-signalling pathways in B. megaterium is not known. However, it is possible that the regulatory pathway represents a response to exogenous environmental fatty acids. Phytanic acid represents an excellent example of this, as it is a major breakdown product of vegetative plant matter, and thus will be found in the soil, which is the natural habitat of bacillus species [22] . The regioselectivity of the metabolism of the ω-1 carbon of phytanic acid is in contrast with the multiple points of metabolism seen for simple saturated fatty acids. Straight-chain saturated fatty acids such as palmitic and stearic acid are hydroxylated promiscuously at the ω-1, 2 or 3 positions. However, recent studies have also shown that cytochrome P-450 BM-$ can metabolize the highly unsaturated arachidonic and eicosapentanoic acids with exquisite regioselectivity [23] .
We have previously remarked on the close parallels between the regulation of cytochrome P-450 BM-$ and that of the mammalian CYP4A gene family [5, 6] . There is growing evidence that the induction of cytochrome P-450 gene expression in mammals by foreign compounds can either be an adaptive response to toxic environmental challenge or through molecular mimicry of endogenous signalling involved in normal metabolic homoeostasis [24] . The peroxisome proliferators activate the transcription of both cytochrome P-450 BM-$ and the mammalian fatty acid hydroxylases. In the case of the mammalian enzymes, the fatty acids activate a nuclear receptor known as the peroxisome proliferator-activated receptor [25] . This receptor binds to the regulatory regions of the CYP4A genes as a heterodimer with the retinoid X receptor and mediates a peroxisome proliferator-dependent activation of transcription of these genes [26] . With this in mind it is particularly relevant to note that phytanic acid is a xenobiotic in mammals but is not an activator of the peroxisome proliferator-activated receptor\ retinoid X receptor heterodimer [27] . The peroxisome proliferator-activated receptor has been shown to be a sensor for straight-chain unsaturated fatty acids [24, 28] . In contrast, phytanic acid and its immediate precursor, phytenic acid, bind and activate homodimers of the nuclear retinoid X receptor [27, 29] . This homodimeric complex may activate an overlapping subset of target genes that are also activated by peroxisome proliferator-activated receptor\retinoid X receptor, as the result of the similarity of their response elements [30] . We have not yet examined the potential for phytanic acid to regulate the CYP4A genes in rodents.
A human syndrome known as Refsum's disease is caused by a deficiency in phytanic acid metabolism [22] . Increased levels of phytanic acid are found in the tissues of afflicted individuals. These individuals suffer from neuropathies and retinal disorders which are reduced when a phytanic acid-free diet is implemented. mimic, and examination of the branched structure of phytanic acid reveals similarity to retinoids including all-trans-retinoic acid and 9-cis-retinoic acid (Figure 7 ). Studies are in progress to determine if retinoids are effective inducers of cytochrome P-450 BM-$ .
It will be intriguing to establish whether there are further parallels between the B. megaterium system and the mammalian system, as this could provide further insight into how fatty acids and other lipophilic nutrient signals may be acting as transcriptional regulators of gene expression.
